Gefitinib: Targeted Therapy for Non-Small Cell Lung Cancer
Gefitinib is a targeted therapy medication that has significantly improved the treatment of non-small cell lung cancer (NSCLC). Marketed under various brand names, Gefitinib works by inhibiting the epidermal growth…